Non-Small Cell Lung Cancer Treatment Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Lung Cancer

The global non-small cell lung cancer (NSCLC) treatment market is estimated to be valued at US$ 24,910.7 million in 2022 and is expected to exhibit a CAGR of 9.4% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Non-small cell lung cancer (NSCLC) is a type of … Read more